診療科・部門紹介
診療科・部門紹介

食道外科

食道外科

最終更新日 : 2021年5月17日

診療科の特徴診療実績スタッフ紹介|トピックス

【2014】

  1. Watanabe M, Mine S, Yamada K, Shigaki H, Baba Y, Yoshida N, Kajiyama K, Yamamoto N, Sano T, Baba H:
    Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Gen Thorac Cardiovasc Surg 62(11):685-92, 2014.
  2. 渡邊雅之, 志垣博信, 松本晶, 西田康二郎, 峯真司:
    食道癌の疫学と発癌リスク
    Pharma Medica 32(7):9-12, 2014.
  3. 渡邊雅之, 吉田直矢, 馬場祥史, 井田智, 馬場秀夫:
    頸部食道癌に対する集学的治療戦略.
    日本気管食道科学会会報 65(2):142-3, 2014.

【2015】

  1. Mine S, Nunobe S, Watanabe M:
    A novel technique of anti-reflux esophagogastrostomy following left thoracoabdominal esophagectomy for carcinoma of the esophagogastric junction.
    World J Surg 39(9): 2359-2361, 2015.
  2. Saeki H, Watanabe M, Mine S, Shigaki H, Oya S, Ishiyama A, Tsuchida T, Fujisaki J, Baba H, Maehara Y, Sano T:
    Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection.
    J Gastroenterol 50(4): 406-413, 2015.
  3. Watanabe M, Mine S, Nishida K, Yamada K, Shigaki H, Matsumoto A, Sano T:
    Salvage esophagectomy after definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: Who really benefits from this high-risk surgery?
    Ann Surg Oncol22(13): 4438-4444, 2015.
  4. Watanabe M:
    Risk factors and molecular mechanisms of esophageal cancer: differences between the histologic subtypes.
    J Cancer Metastasis Treat 1: 1-7, 2015.
  5. Hiyoshi Y, Watanabe M:
    MicroRNAs in gastrointestinal cancer: a novel biomarker and its clinical application.
    J Cancer Metastasis Treat 3: 144-155, 2015.
  6. Imamura Y, Tokunaga R, Nakamura K, Baba H, Watanabe M:
    Overview of genetic alterations in the pathogenesis of esophagogastric junctional adenocarcinoma and esophageal adenocarcinoma: recent findings by next generation sequencing.
    J Cancer Metastasis Treat3: 123-129, 2015.
  7. Ida S, Watanabe M, Baba H:
    Chronic inflammation and gastrointestinal cancer.
    J Cancer Metastasis Treat 3: 138-143, 2015.
  8. Eto K, Watanabe M:
    Trends in clinical use of targeted therapy for gastrointestinal cancers. J Cancer Metastasis Treat 3: 163-171, 2015.
  9. Shigaki H, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H:
    Epigenetics in GI cancer.
    J Cancer Metastasis Treat 3: 113-122, 2015.
  10. Matsumoto A, Watanabe M, Shigaki H, Okumura Y, Nishida K, Mine S, Yamada K, Yanaga K, Sano T:
    Intussusception causing postoperative intestinal obstruction following free jejunal transfer in adults: two case reports and review of the literature.
    Surg Case Rep 1: 28, 2015.
  11. Oya S, Mine S, Watanabe M, Yamada K:
    Oesophageal cancer with an aberrant right subclavian artery accompanied by a thoracic duct anomaly.
    Eur J Cardiothorac Surg 48(3): e55-57, 2015.
  12. Watanabe M:
    Editorial: Introduction to volume 1 issue 3 of Journal of Cancer Metastasis and Treatment.
    J Cancer Metastasis Treat 1(3): 111-112, 2015.
  13. 渡邊雅之:
    消化器外科のドレーン看護.
    消化器外科NURSING 2015春季増刊号 84-87, 2015.
  14. 渡邊雅之、黒河内喬範、岡村明彦、今村裕、本多通孝、西田康二郎、峯真司:
    食道外科における消化管吻合のコツ‐器械吻合.
    臨床外科 70(10): 1211-1216, 2015.

【2016】

  1. Matsumoto A, Watanabe M, Shigaki H, Nishida K, Mine S, Sano T, Yanaga K:
    Efficacy of staged treatment strategy for patients with synchronous double cancers of the esophagus and head and neck: a retrospective study.
    World J Surg 40(2): 388-394, 2016.
  2. Mine S, Watanabe M:
    A commentary on 'Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia'.
    Transl Gastroenterol Hepatol 1: 12, 2016.
  3. Okamura A, Watanabe M, Kurogochi T, Imamura Y, Nishida K, Mine S: Mediastinal Adiposity Influences the Technical Difficulty of Thoracic Procedure in Minimally Invasive Esophagectomy.
    World J Surg 40(10): 2398-2404, 2016.
  4. Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, Sano T:
    Factors influencing difficulty of the thoracic procedure in minimally invasive esophagectomy.
    Surg Endosc 30(10): 4279-4285, 2016.
  5. Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, Kitagawa Y, Sano T:
    Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma.
    Ann Surg Oncol 23(4): 1387-1394, 2016.
  6. Okamura A, Watanabe M, Mine S, Nishida K, Kurogochi T, Imamura Y: Spirometric lung age predicts postoperative pneumonia after esophagectomy.
    World J Surg 40(10): 2412-2418, 2016.
  7. Watanabe M, Mine S, Nishida K, Yamada K, Shigaki H, Oya S, Matsumoto A, Kurogochi T, Okamura A, Imamura Y, Sano T:
    Improvement in short-term outcomes after esophagectomy with a multidisciplinary perioperative care team.
    Esophagus 13(4): 337-342, 2016.
  8. Watanabe M, Mine S, Nishida K, Kurogochi T, Okamura A, Imamura Y: Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy.
    Gen Thorac Cardiovasc Surg 64(8): 457-463, 2016.
  9. 渡邊雅之:
    食道癌の術後障害とその対策.
    日本気管食道科学会専門医通信 52: 12-18, 2016.
  10. 渡邊雅之、志垣博信、松本晶、西田康二郎、峯真司、佐野武、山口俊晴:
    食道癌の治療方針決定に必要な画像診断.
    コンセンサス癌治療 14(1): 2-7, 2016.
  11. 渡邊雅之、藤井亜砂美:
    食道亜全摘・3領域リンパ節郭清・胃管再建(頸部食道胃管吻合)のドレーン.
    消化器外科NURSING. 21 (6): 58, 2016.
  12. 渡邊雅之、藤井亜砂美:
    中下部食道切除・2領域リンパ節郭清・胃管再建(胸腔内食道胃管吻合)のドレーン.
    消化器外科NURSING. 21 (6): 59, 2016.
  13. 峯真司、渡邊雅之、新橋渉:
    イラストで学ぶ消化器外科再建法のすべて.食道.空腸再建 遊離空腸再建.
    外科 78(12): 1294-1297, 2016.

【2017】

  1. Mine S, Watanabe M, Imamura Y, Okamura A, Kurogochi T, Sano T:
    Clinical significance of the pre-therapeutic nodal size in patients undergoing neo-adjuvant treatment followed by esophagectomy for esophageal squamous cell carcinoma.
    World J Surg 41(1): 184-190, 2017.
  2. Okamura A, Watanabe M, Imamura Y, Kamiya S, Yamashita K, Kurogochi T, Mine S:
    Preoperative glycosylated hemoglobin levels predict the anastomotic leak after esophagectomy with cervical esophagogastric anastomosis. World J Surg 41(2): 200-207, 2017.
  3. Matsumoto A, Watanabe M, Mine S, Nishida K, Shigaki H, Kawabata K, Yanaga K, Sano T:
    Comparison of synchronous versus staged surgeries for patients with synchronous double cancers of the esophagus and head-and-neck.
    Dis Esophagus 30(1): 1-6, 2017.
  4. Hayami M, Hiki N, Nunobe S, Mine S, Ohashi M, Kumagai K, Ida S, Watanabe M, Sano T, Yamaguchi T:
    Clinical outcomes and evaluation of laparoscopic proximal gastrectomy with double^flap technique for early gastric cancer in the upper third of the stomach.
    Ann Surg Oncol 24(6): 1635-1642, 2017.
  5. Yamashita K, Watanabe M, Mine S, Kurogochi T, Okamura A, Hayami M, Imamura Y:
    Patterns and outcomes of recurrent esophageal cancer after curative esophagectomy.
    World J Surg 41(9): 2337-2344, 2017.
  6. Okamura A, Watanabe M, Imamura Y, Hayami M, Yamashita K, Kurogochi T, Mine S:
    Glycemic status and prognosis of patients with squamous cell carcinoma of the esophagus.
    World J Surg 41(10): 2591-2597, 2017.
  7. Mine S, Watanabe M, Okamura A, Imamura Y, Kajiyama Y, Sano T:  Superior thoracic aperture size is significantly associated with cervical anastomotic leakage after esophagectomy.
    World J Surg 41(10): 2598-2604, 2017.
  8. Shigaki H, Imamura Y, Mine S, Okamura A, Kurogochi T, Yamashita K, Watanabe M:
    Clinicopathologic features of esophageal squamous cell carcinoma in never smoker-never drinkers.
    Dis Esophagus 30(5): 1-7, 2017.
  9. Okamura A, Watanabe M, Mine S, Kurogochi T, Yamashita K, Hayami M, Imamura Y, Ogura M, Ichimura T, Takahari D, Chin K:
    Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Dis Esophagus 30(9): 1-8, 2017.
  10. Okamura A, Watanabe M, Imamura Y, Hayami M, Yuda M, Yamashita K, Shoji Y, Mine S:
    Cervicothoracoscopic approach in esophagectomy.
    Ann Surg Oncol 25(1): 333, 2017.
  11. Hayami M, Watanabe M, Ishizuka N, Nine S, Imamura Y, Okamura A, Kurogochi T, Yamashita K:
    Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy.
    J Surg Oncol. doi: 10.1002/jso.24941, 2017.
  12. Okamura A, Watanabe M, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S:
    Implication of visceral obesity in patients with esophageal squamous cell carcinoma.
    Langenbeck Arch Surg doi: 10.1007/s00423-017-1643-0, 2017.
  13. Watanabe M:
    Editorial: Transcription factor SPZ1 may promote TWIST-mediated epithelial-mesenchymal transition in thoracic malignancies.
    J Thorac Dis 9(9): 2740-2742, 2017.
  14. Kurogochi T, Mine S, Kawachi H:
    Anti-neutrophil cytoplasmic antibody-associated vasculitis resembling esophageal cancer. Dig Endosc 2017; 29: 236-237.
  15. 峯真司、渡邊雅之:
    食道癌外科治療のすべて:食道癌の治療方針および手術適応の評価.
    外科79 (4): 301-304, 2017.
  16. 岡村明彦、渡邊雅之、今村裕、神谷諭、速水克、山下公太郎、黒河内喬範、峯真司:
    反回神経麻痺の診断と治療. 胸腔鏡下食道切除術後反回神経麻痺の現状と術後肺炎予防における周術期管理チームの意義.
    日本気管食道科学会誌. 68(2): 189-191, 2017
  17. 岡村明彦、渡邊雅之:
    特集:胸部外科領域における合併症予防のための周術期管理 食道癌周術期管理におけるチーム医療. 胸部外科 70 (8): 712-715, 2017.
  18. 渡邊雅之、山下公太郎、湯田匡己、速水克、岡村明彦、今村裕、峯真司:
    特集/わかりやすい消化管癌診療のコンセンサス.食道癌.胸腔鏡手術.臨床と研究 94(12): 1479-1483, 2017.
  19. 梅野博仁、渡邊雅之:
    ワークショップ3反回神経麻痺の診断と治療 司会者のまとめ. 
    日本気管食道科学会誌68 (2) 185-186, 2017.

【2018】

  1. Okamura A, Watanabe M, Imamura Y, Hayami M, Yuda M, Yamashita K, Shoji Y, Mine S: Cervicothoracoscopic approach in esophagectomy. Ann Surg Oncol. 2018; 25(1), 333.
  2. Pectasides E, Stachler MD, Derks S, Liu Y, Maron S, Islam M, Alpert L, Kwak H, Kindler H, Polite B, Sharma MR, Allen K, O'Day E, Lomnicki S, Maranto M, Kanteti R, Fitzpatrick C, Weber C, Setia N, Xiao SY, Hart J, Nagy R, Kim KM, Choi MG, Min BH, Nason KS, O'Keefe L, Watanabe M, Baba H, Lanman R, Agoston AT, Oh DJ, Dunford A, Thorner AR, Ducar MD, Wollison BM, Coleman HA, Ji Y, Posner MC, Roggin KK, Turaga K, Chang P, Hogarth K, Siddiqui U, Gelrud A, Ha G, Freeman SS, Rhoades J, Reed S, Gydush G, Rotem D, Davison J, Imamura Y, Adalsteinsson V, Lee J, Bass AJ, Catenacci DV: Genomic heterogeniety as a barrier to precision medicine in gastroesophageal adenocarcinoma. Cancer Discov 2018; 8(1): 37-48.
  3. Hayami M, Watanabe M, Ishizuka N, Nine S, Imamura Y, Okamura A, Kurogochi T, Yamashita K: Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy. J Surg Oncol, 2018; 117(6): 1251-1259.
  4. Okamura A, Watanabe M, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S: Implication of visceral obesity in patients with esophageal squamous cell carcinoma. Langenbeck Arch Surg. 2018; 403(2): 245-253.
  5. Okamura A, Watanabe M, Yuda M, Shoji Y, Yamashita K, Hayami M, Imamura Y, Mine S: Cervicothoracoscopic Approach for Esophageal Cancer in a Patient with Right-Sided Aortic Arch Ann Surg Oncol. 2018; 25(5): 1287.
  6. Yamashita K, Watanabe M, Mine S, Fukudome I, Okamura A, Yuda M, Hayami M, Imamura Y: The impact of the Charlson comorbidity index on the prognosis of esophageal cancer patients who underwent esophagectomy with curative intent. Surg Today, 2018; 48(6): 632-639.
  7. Okamura A, Watanabe M, Fukudome I, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S: Surgical team proficiency in minimally invasive esophagectomy is related to case volume and improves patient outcome. Esophagus 2018; 15(2): 115-121.
  8. Wong GS, Zhou J, Liu JB, Wu Z, Xu X, Li T, Schumacher SE, Puschhof J, McFarland J, Zou C, Dulak A, Henderson L, Xu P, O'Day E, Rendak R, Liao WL, Cecchi F, Hembrough T, Schwartz S, Szeto C, Rustgi AK, Wong KK, Diehl JA, Jensen K, Graziano F, Ruzzo A, Fereshetian S, Merthins P, Carr SA, Beroukhim R, Nakamura K, Oki E, Watanabe M, Baba H, Imamura Y, Catenacci D, Bass AJ. Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 2018; 24(7): 968-977.
  9. Okamura A, Watanabe M, Kozuki R, Toihata T, Yuda M, Imamura Y, Mine S: Supraclavicular and celiac metastases in squamous cell carcinoma of the middle thoracic esophagus. Langenbecks Arch Surg, 403(8): 977-984, 2018    
  10. Cañadas I, Thummalapalli R, Kim JW, Kitajima S, Jenkins RW, Christensen CL, Campisi M, Kuang Y, Zhang Y, Gjini E, Zhang G, Tian T, Sen DR, Miao D, Imamura Y, Thai T, Piel B, Terai H, Aref AR, Hagan T, Koyama S, Watanabe M, Baba H, Adeni AE, Lydon CA, Tamayo P, Wei Z, Herlyn M, Barbie TU, Uppaluri R, Sholl LM, Sicinska E, Sands J, Rodig S, Wong KK, Paweletz CP, Watanabe H, Barbie DA: Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med. 2018, 24(8): 1143-1150.
  11. Yamashita K, Watanabe M, Mine S, Toihata T, Fukudome I, Okamura A, Yuda M, Hayami M, Ishizuka N, Imamura Y: Minimally-invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. Surg Endosc 2018; 32(11): 4443-4450.
  12. Okamura A, Watanabe M, Fukudome I, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S: Relationship between visceral obesity and postoperative inflammatory response following minimally invasive esophagectomy. World J Surg 2018; 42(11):3651-3657.
  13. Bahcall M, Awad MM, Sholl LM, Wilson FH, Xu M, Wang S, Palakurthi S, Choi J, Ivanova EV, Leonardi GC, Ulrich BC, Pawelets CP, Kirschmeier PT, Watanabe M, Baba H, Nishino M, Nagy RJ, Lanman RB, Capelletti M, Chambers ES, Redig AJ, VanderLaan PA, Costa DB, Imamura Y, Janne PA: Amplification of wild-type KRAS impacts resistance to crizotinib in MET exon 14 mutant non-small cell lung cancer. Clin Cancer Res 2018, 24(23):5963-5976.
  14. Mine S, Watanabe M, Kumagai K, Okamura A, Yamashita K, Hayami M, Yuda M, Imamura Y, Ishizuka N: Oesophagectomy with or without supraclavicular lymphadenectomy after neoadjuvant treatment for squamous cell carcinoma of the oesophagus. Br J Surg 2018, 105:1793-1798.
  15. Watanabe M, Okamura A, Toihata T, Yamashita K, Yuda M, Hayami M, Fukudome I, Imamura Y, Mine S: Recent progress in perioperative management of patients undergoing esophagectomy for esophageal cancer. Esophagus, 2018; 15: 160-164.
  16. Watanabe M:
     Recent topics and perspectives on esophageal cancer in Japan. JMA journal, 2018; 1(1)30-39.
  17. Watanabe M:
     Introduction to the special issue on reviews of gastric cancer metastasis and treatment. J Cancer Metastasis Treat 2018; 4:48.
  18. Nakamura K, Iwatsuki M, Kurashige J, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H: Circulating tumor cells in gastric cancer. J Cancer Metastasis Treat. 2018; 4: 32.
  19. Toihata T, Imamura Y, Watanabe M, Baba H: Management of metastatic esophagogastric junction adenocarcinoma. J Cancer Metastasis Treat 2108; 4: 24.
  20. Ida S, Watanabe M: Coversion surgery for stage IV gastric cancer. J Cancer Metastasis Treat. 2018; 4: 22.
  21. Eto K, Ida S, Watanabe M, Baba H: Treatment strategy for metastatic gastric cancer in Japan. J Cancer Metastasis Treat. 2018; 4: 23.
  22. Watanabe M, Baba H: Biological basis of esophageal squamous cell carcinoma: Modern Thoracic Oncology, 1st edition. Singapore, World Scientific, 2018, pp3-5.
  23. 渡邊雅之:NEW BED-SIDE MEMO surgery.食道癌 大道学館出版部, 2018, pp1-29.
  24. 渡邊雅之:
    ベッドサイドメモ.食道癌 大道学館出版部, 2018, pp1-29.
  25. 渡邊雅之,問端 輔,上月亮太郎:食道再建術(再建のみ).5年でマスター消化器外科標準手術 消化器外科専門医への道.メジカルビュー社, 2018, pp74-83.
  26. 渡邊雅之:消化器悪性疾患におけるビッグデータの意義と役割.4.胃癌.消化器疾患の最新医療.先端医療技術研究所, 2018, pp44-47.

【2019】

  1. Baba Y, Yagi T, Kosumi K, Okadome K, Nomoto D, Eto K, Hiyoshi Y, Nagai Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Komohara Y, Watanabe M, Baba H. Morphological lymphatic reaction, patient prognosis and PD-1 expression after surgical resection for oesophageal cancer. Br J Surg 2019; 106(10): 1352-1361.
  2. Yoshida N., Nagai Y., Baba Y., Miyamoto Y., Iwagami S., Iwatsuki M., Hiyoshi Y., Eto K., Ishimoto T., Kiyozumi Y., Nomoto D., Akiyama T., Imamura Y., Watanabe M., Baba H. Effect of resection of the thoracic duct and surrounding lymph nodes on short- and long- term and nutritional outcomes after esophagectomy for esophageal cancer. Ann Surg Oncol 2019; 26(9): 1893-1900.
  3. Hayami M., Watanabe M., Mine S., Imamura Y., Okamura A., Yuda M., Yamashita K., Toihata T., Shoji Y., Ishizuka N. Lateral thermal spread induced by energy devices: a porcine model to evaluate the influence on the recurrent laryngeal nerve. Surg Endosc 2019; 33(12): 4153-4163.
  4. Yamashita K., Mine S., Toihata T., Fukudome I., Okamura A., Yuda M., Hayami M., Imamura Y., Watanabe M. The usefulness of three-dimentional video-assisted thoracoscopic esophagectomy in esophageal cancer patients. Esophagus 2019; 16(3): 272-277.
  5. Takahashi K, Mine S, Kozuki R, Toihata T, Okamura A, Imamura Y, Watanabe M. Ivor-Lewis esophagectomy for patients with squamous cell carcinoma of the thoracic esophagus with a history of total pharyngolaryngectomy. Esophagus 2019; 16(4): 382-385.
  6. Kurogochi T, Honda M, Yamashita K, Hayami M, Okamura A, Imamura Y, Mine S, Watanabe M. Safety and efficacy of preoperative chemotherapy followed by esophagectomy versus upfront surgery for resectable esophageal squamous cell carcinoma. Surg Today. 2019; 49 (2): 150-157.
  7. Yagi T, Baba Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. PD-L1 expression, tumor-infiltrating lymphocytes, and clinical outcome in patients with surgically resected esophageal cancer Ann Surg 2019; 269(3): 471-478.
  8. Yagi T., Baba Y., Okadome K., Kiyozumi Y., Hiyoshi Y., Ishimoto T., Iwatsuki M., Miyamoto Y., Yoshida N., Watanabe M., Kamohara Y., Baba H. Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer. Eur J Cancer 2019; 111: 38-49.
  9. Hirayama, Y., Fujisaki, J., Yoshimizu, S., Horiuchi, Y., Yoshio, T., Ishiyama, A., Hirasawa, T., Imamura, Y., Mine, S., Watanabe, M.,  Tsuchida, T. Efficacy and safety of endoscopic resection for gastric tube cancer after surgical resection of esophageal squamous cell carcinoma Esophagus, 2019; 16(2): 194-200.
  10. Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Hitoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Idoleamine 2,3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer Cancer Sci 2019; 110(6): 1863-1871.
  11. Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Kamohara Y, Baba H. IDO1 expression is associated with immune tolerance and poor prognosis in patients with surgically resected esophageal cancer. Ann Surg 2019; 269(6): 1101-1108.
  12. Mine S, Watanabe M, Kumagai K, Okamura A, Yuda M, Hayami M, Yamashita K, Imamura Y, Ishizuka N. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction. Dis Esophagus 2019; 32(11): 1-8.
  13. Mine S, Watanabe M. Reply to: Is there really no difference of mediastinal lymph node metastasis pattern between esophageal adenocarcinoma and squamous cell carcinoma? Dis Esophagus 2019; 32(7)
  14. Yoshida N, Morito A, Nagai Y, Baba Y, Miyamoto Y, Iwagami S, Iwatsuki M, Hiyoshi Y, Eto K, Ishimoto T, Kiyozumi Y, Yagi T, Nomoto D, Akiyama T, Toihata T, Imamura Y, Watanabe M, Baba H. Clinical importance of sputum in the respiratory tract as a predictive marker of postoperative morbidity after esophagectomy for esophageal cancer. Ann Surg Oncol. 2019; 26(8)2580-2586.
  15. Okamura A, Watanabe M, Kozuki R, Toihata T, Takahashi K, Imamura Y, Mine S. Significance of intramural metastasis in patients with esophageal squamous cell carcinoma: An indicator of aggressive cancer behavior. World J Surg 2019; 43(8): 1997-2005.
  16. Takahashi K, Watanabe M, Kozuki R, Toihata T, Okamura A, Imamura Y, Mine S, Ishizuka N. Prognostic significance of skeletal muscle loss during early postoperative period in elderly patients with esophageal cancer. Ann Surg Oncol 2019; 26(11):3727-3735.
  17. Okamura A, Watanabe M. Author's reply: Significance of intramural metastasis in patients with esophageal squamous cell carcinoma: An indicator of aggressive cancer behavior. World J Surg 2019; 43(10): 2649-2650.
  18. Toh Y, Yamamoto H, Miyata H, Gotoh M, Watanabe M, Matsubara H, Kakeji Y, Seto Y. . Significance of the board-certified surgeon systems and clinical practice guideline adherence to surgical treatment of esophageal cancer in Japan: a questionnaire survey of departments registered in the National Clinical Database. Esophagus 2019; 16(4): 362-370.
  19. Kalikawe R, Baba Y, Nomoto D, Okadome K, Miyake K, Eto K, Hiyoshi Y, Nagai Y, Iwatski M, Ishimoto T, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Lysyl oxidase impacts disease outcomes and correlates with grobal DNA hypomethylation in esophageal cancer. Cancer Sci 2019; 110 (12): 3727-3737.
  20. Okamura A, Yamaashita K, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M. Inflammatory response and recurrence after minimally invasive esophagectomy. Langenbecks Arch Surg 2019, 404(6): 761-769.
  21. Imamura, Y., Watanabe, M., Toihata, T., Takamatsu, M., Kawachi, H., Haraguchi, I., Ogata, Y., Yoshida, N., Saeki, H., Oki, E., Taguchi, K., Yamamoto, M., Morita, M., Mine, S., Hiki, N., Baba, H., Sano, T. Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients Digestion, 99(1): 6-13, 2019  
  22. 渡邊雅之、峯真司、高橋慶太、問端輔、上月亮太郎、今村裕、岡村明彦.食道癌における頸部郭清術 胸部食道癌に対する鎖骨上リンパ節郭清の意義.日本気管食道科学会会報 2019; 70: 164-167.
  23. 岡村明彦、渡邊雅之、上月亮太郎、高橋慶太、問端輔、今村裕、峯真司.食道扁平上皮癌における壁内転移の意義.日本気管食道科学会会報 2019; 70: 225-230.
  24. 高橋慶太、上月亮太郎、問端輔、岡村明彦、今村裕、峯真司、渡邊雅之.人生100年時代における高齢者栄養療法 高齢者食道癌術後の骨格筋減少が再発・予後に与える影響について.外科と代謝・栄養.2019; 53: 92.
  25. 渡邊雅之.ナースがおさえる正常&異常のポイントこれだけ!消化器癌治療後の過程 まるみえ!タイムライン:食道の治療とケア.消化器外科Nursing 2019; 24: 410-417.
  26. 岡村明彦、渡邊雅之、上月亮太郎、高橋慶太、問端輔、今村裕、峯真司.食道癌手術 術中・術後合併症を起こさないコツ:術中・術後合併症を軽減する手術主義の工夫と周術期管理.消化器外科2019; 42: 913-922.
  27. 渡邊雅之、大竹玲子、問端輔、高橋慶太、上月亮太郎、岡村明彦、今村裕.食道癌に対する気管分岐部および気管支周囲リンパ節郭清.消化器外科 2019; 42: 1309-1317.
  28. 渡邊雅之、岡村明彦、上月亮太郎、高橋慶太、問端輔、大竹玲子、陳勁松、鈴木健、羽田忍、高瀬鮎美、早坂紀子.【臓器別がん Basic & New 症例FILE付き 食道がん】.YORI-SOU がんナーシング 2019; 9: 733-748.

このページのTOPへ